Orkla (ORK) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
12 Feb, 2026Executive summary
Organic growth for Q4 2025 was 4.5% year-over-year, with underlying adjusted EBIT for consolidated portfolio companies up 17% and adjusted EPS of NOK 1.74, reflecting strong operational performance and margin improvement.
Jotun delivered 28% underlying operating profit growth, and Orkla Snacks achieved 16% EBIT adjusted growth in Q4, with all major portfolio companies except Foods contributing positively.
The Board proposes a total dividend of NOK 6 per share for 2025, including an extra NOK 2.2, and a NOK 4 billion share buyback program is ongoing.
Strategic progress included the IPO of Orkla India, sale of Hydro Power assets, and further portfolio simplification.
Full-year 2025 saw organic growth of 3.5%, underlying EBIT (adj.) growth of 7%, and cash conversion of 101%.
Financial highlights
Q4 2025 operating revenues were NOK 18,775 million, up 2% year-over-year; adjusted EBIT was NOK 1,977 million, up 12%.
Adjusted EPS reached NOK 1.74, up 24% year-over-year; profit before tax rose 24% to NOK 2,140 million.
Cash flow from operations was NOK 7.8 billion for 2025, with cash flow before capital allocation at NOK 6.9 billion.
Net debt stood at NOK 14.2 billion, equal to 1.4x EBITDA (0.9x excluding Orkla Food Ingredients).
Profit from associates and JVs was NOK 505 million, up 36% year-over-year, mainly from Jotun.
Outlook and guidance
Jotun expects sales growth to outpace the market in 2026, but margin pressure from competition and negative currency effects is anticipated.
Portfolio companies are targeting 8–10% CAGR in underlying adjusted EBIT and 1.5–2.0 pp margin improvement through 2026.
Orkla Snacks anticipates favorable input cost development in 2026, while Orkla Health expects continued negative impact from cod liver oil price trends.
Inflation in key input costs (meat, marine, berries, cocoa) is expected to persist into 2026.
Portfolio companies are developing strategy plans for 2027–2030, focusing on volume growth and cost efficiency.
Latest events from Orkla
- Revenue rose 13.7%, EPS climbed 30.2%, and a NOK 2.60 dividend was proposed.ORK
AGM 2017 presentation - A branded-goods pivot paired 2011 growth with portfolio exits and shareholder returns.ORK
AGM 2012 presentation - AGM approved the dividend, renewed share authorities and confirmed governance appointments.ORK
AGM 2011 - Stangeland and Kjos appointments, Deputy Chair remuneration and electronic communications approved.ORK
EGM 2026 - Flat organic growth and 2.5% EBIT rise offset by currency and margin pressures.ORK
Q2 2026 - Organic growth of 4.9% and 3% EBIT growth, with strong segments but rising cost pressures.ORK
Q1 2026 - FY2025 growth supported a NOK 6/share dividend and portfolio reshaping; the plastic proposal was rejected.ORK
AGM 2026 - Aims for 12-14% annual TSR with stable dividends and a NOK 4B share buyback in 2025-26.ORK
Investor presentation - Q1 2025 delivered 7.6% EBIT growth, 19% higher EPS, and strong margin and cash flow gains.ORK
Q1 2025